UMB Bank’s Revolution Medicines RVMD Stock Holding History

UMB Bank’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.05K	Buy	43 +18	+72%	+$2.63K	﹤0.01%	1992
2026 Q1	$2.43K	Buy	25 +19	+317%	+$1.92K	﹤0.01%	2141
2025 Q4	$478	Buy	+6	New	+$393	﹤0.01%	2253

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

UMB Bank's RVMD Position: Q2 2026 in Review

UMB Bank increased its Revolution Medicines (RVMD) stake by 72% in Q2 2026, buying an estimated $2.63K and bringing the position to 43 shares worth $8.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

UMB Bank first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

UMB Bank held 43 shares of Revolution Medicines worth $8.05K as of Q2 2026.
UMB Bank bought 18 Revolution Medicines shares in Q2 2026, an estimated $2.63K.
Revolution Medicines made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1992 holding.
UMB Bank first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.